Chiasma begins enrolment in Phase III trial for acromegaly

Chiasma has started patient enrolment in Phase III CHIASMA OPTIMAL clinical trial of its product candidate Mycapssa (octreotide capsules) as a maintenance therapy to treat adults with acromegaly.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news